Targeting gastrin-releasing peptide as a new approach to treat aggressive refractory neuroblastomas

Surgery

Volumn 149, Issue 3, 2011, Pages 425-432

  Paul, Pritha ^a,b   Gillory, Lauren A ^c   Kang, Junghee ^c   Qiao, Jingbo ^a   Chung, Dai H ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ETOPOSIDE; GASTRIN RELEASING PEPTIDE; MOLECULAR MARKER; PROTEIN P21; PROTEIN P53; SMALL INTERFERING RNA; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL STRAIN JF; CELL STRAIN SK N SH; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; DRUG TARGETING; FLOW CYTOMETRY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; MONOTHERAPY; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; ETOPOSIDE; GASTRIN-RELEASING PEPTIDE; HUMANS; NEUROBLASTOMA; POLY(ADP-RIBOSE) POLYMERASES; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; VINCRISTINE;

EID: 79951943908     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2010.08.011     Document Type: Article

References (26)

1. Chesler L, Goldenberg DD, Collins R, Grimmer M, Kim GE, Tihan T, et al. Chemotherapy-induced apoptosis in a transgenic model of neuroblastoma proceeds through p53 induction. Neoplasia 2008;10:1268-74.
2. Michaelis M, Klassert D, Barth S, Suhan T, Breitling R, Mayer B, et al. Chemoresistance acquisition induces a global shift of expression of aniogenesis-associated genes and increased pro-angogenic activity in neuroblastoma cells. Mol Cancer 2009;8:80.
3. Fan M, Goodwin M, Vu T, Brantley-Finley C, Gaarde WA, Chambers TC. Vinblastine-induced phosphorylation of Bcl-2 and Bcl-XL is mediated by JNK and occurs in parallel with inactivation of the Raf-1/MEK/ERK cascade. J Biol Chem 2000;275:29980-5.
4. Gomber S, Dewan P, Chhonker D. Vincristine induced neurotoxicity in cancer patients. Indian J Pediatr 2010;77:97-100.
5. Day TW, Wu CH, Safa AR. Etoposide induces protein kinase Cdelta- and caspase-3-dependent apoptosis in neuroblastoma cancer cells. Mol Pharmacol 2009;76:632-40.
6. Patel O, Shulkes A, Baldwin GS. Gastrin-releasing peptide and cancer. Biochim Biophys Acta 2006;1766:23-41. (Pubitemid 44175629)
7. Kim S, Hu W, Kelly DR, Hellmich MR, Evers BM, Chung DH. Gastrin-releasing peptide is a growth factor for human neuroblastomas. Ann Surg 2002;235:621-9.
8. Ishola TA, Kang J, Qiao J, Evers BM, Chung DH. Phosphatidylinositol 3-kinase regulation of gastrin-releasing peptideinduced cell cycle progression in neuroblastoma cells. Biochim Biophys Acta 2007;1770:927-32. (Pubitemid 46617033)
9. Qin Y, Halmos G, Cai RZ, Szoke B, Ertl T, Schally AV. Bombesin antagonists inhibit in vitro and in vivo growth of human gastric cancer and binding of bombesin to its receptors. J Cancer Res Clin Oncol 1994;120:519-28. (Pubitemid 24246568)
10. Kang J, Ishola TA, Baregamian N, Mourot JM, Rychahou PG, Evers BM, et al. Bombesin induces angiogenesis and neuroblastoma growth. Cancer Lett 2007;253:273-81. (Pubitemid 47017542)
11. Zhou J, Chen J, Zhong R, Mokotoff M, Shultz LD, Ball ED. Targeting gastrin-releasing peptide receptors on small cell lung cancer cells with a bispecific molecule that activates polyclonal T lymphocytes. Clin Cancer Res 2006;12:2224-31.
12. Stangelberger A, Schally AV, Letsch M, Szepeshazi K, Nagy A, Halmos G, et al. Targeted chemotherapy with cytotoxic bombesin analogue AN-215 inhibits growth of experimental human prostate cancers. Int J Cancer 2006;118:222-9. (Pubitemid 41681603)
13. Zhou J, Chen J, Mokotoff M, Zhong R, Shultz LD, Ball ED. Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer. Clin Cancer Res 2003;9:4953-60.
14. KangJH,RychahouPG, IsholaTA,QiaoJ,EversBM,ChungDH. MYCN silencing induces differentiation and apoptosis inhuman neuroblastoma cells. Biochem Biophys Res Commun 2006;351:192-7.
15. Brantley-Finley C, Lyle CS, Du L, Goodwin ME, Hall T, Szwedo D, et al. The JNK, ERK and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin, and etoposide. Biochem Pharmacol 2003;66:459-69. (Pubitemid 36937031)
16. Rozengurt E, Sinnett-Smith J. Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells. Proc Natl Acad Sci U S A 1983;80:2936-40. (Pubitemid 13104152)
17. Alexander RW, Upp JR Jr, Poston GJ, Gupta V, Townsend CM Jr, Thompson JC. Effects of bombesin on growth of human small cell lung carcinoma in vivo. Cancer Res 1988;48:1439-41. (Pubitemid 18091184)
18. Qiao J, Kang J, Cree J, Evers BM, Chung DH. Gastrin-releasing peptide-induced down-regulation of tumor suppressor protein PTEN (phosphatase and tensin homolog deleted on chromosome ten) in neuroblastomas. Ann Surg 2005;241:684-91.
19. Szepeshazi K, Schally AV, Nagy A, Halmos G. Inhibition of growth of experimental human and hamster pancreatic cancers in vivo by a targeted cytotoxic bombesin analog. Pancreas 2005;31:275-82. (Pubitemid 41400486)
20. Kanashiro CA, Schally AV, Zarandi M, Hammann BD, Varga JL. Alterations of EGFR/HER, angiogenesis and apoptosis pathways after therapy with antagonists of growth hormone releasing hormone and bombesin in non-small cell lung cancer. Int J Oncol 2007;30:1019-28.
21. Zhang Q, Bhola NE, Lui VW, Siwak DR, Thomas SM, Gubish CT, et al. Antitumor mechanisms of combined gastrin-releasing peptide receptor and epidermal growth factor receptor targeting in head and neck cancer. Mol Cancer Ther 2007;6:1414-24. (Pubitemid 46712005)
22. Antonoff MB, ChughR, Borja-CachoD, Dudeja V, ClawsonKA, Skube SJ, et al. Triptolide therapy for neuroblastoma decreases cell viability in vitro and inhibits tumor growth in vivo. Surgery 2009;146:282-90.
23. Teitz T, Wei T, Valentine MB, Vanin EF, Grenet J, Valentine VA, et al. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 2000;6:529-35. (Pubitemid 30305902)
24. McKenzie PP, Guichard SM, Middlemas DS, Ashmun RA, Danks MK, Harris LC. Wild-type p53 can induce p21 and apoptosis in neuroblastoma cells but the DNA damage-induced G1 checkpoint function is attenuated. Clin Cancer Res 1999;5:4199-207. (Pubitemid 30013806)
25. Moll UM, Ostermeyer AG, Haladay R, Winkfield B, Frazier M, Zambetti G. Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage. Mol Cell Biol 1996;16:1126-37. (Pubitemid 26061684)
26. McKenzie PP, Danks MK, Kriwacki RW, Harris LC. P21Waf1/Cip1 dysfunction in neuroblastoma: a novel mechanism of attenuating G0-G1 cell cycle arrest. Cancer Res 2003;63:3840-4. (Pubitemid 36793075)